Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thailand To Change “Dominant Position” Definition Of Drug Market Share

This article was originally published in PharmAsia News

Executive Summary

Thailand's Commerce Ministry plans to fix a loophole used by Abbott Laboratories to avoid certain trade competition restrictions. The company withdrew an application to register 10 new drugs in the country last year in response to a government decision to use compulsory licensing to enable production of generic versions of an Abbott HIV/AIDS drug. The Trade Competition Act Committee of the Thai ministry said the law turns on the definition of "dominant position" for products, so the definition is to be changed from applying to those with 50 percent of market share to those with just 25-30 percent. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel